Activation of the tumor suppressive Hippo pathway by triptonide as a new strategy to potently inhibit aggressive melanoma cell metastasis
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 185, 114423
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- The role of melanogenesis in regulation of melanoma behavior: Melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathwaysArchives of Biochemistry and Biophysics, 2014
- The MST1/2-SAV1 complex of the Hippo pathway promotes ciliogenesisNature Communications, 2014
- Cell elasticity is an important indicator of the metastatic phenotype of melanoma cellsExperimental Dermatology, 2014
- Melanoma Resistance: A Bright Future for Academicians and a Challenge for Patient AdvocatesMayo Clinic Proceedings, 2014
- Latest Advances in Chemotherapeutic, Targeted, and Immune Approaches in the Treatment of Metastatic MelanomaMayo Clinic Proceedings, 2014
- Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasisCancer and Metastasis Reviews, 2013
- Acute and subacute toxicity studies on triptolide and triptolide-loaded polymeric micelles following intravenous administration in rodentsFood and Chemical Toxicology, 2013
- Mitochondrial defect drives non-autonomous tumour progression through Hippo signalling in DrosophilaNature, 2012
- Mutational analysis of salvador gene in human carcinomasAPMIS, 2003
- Classification of CEA‐related positivity in primary and metastatic malignant melanomaThe Journal of Pathology, 1994